| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
ZURICH—To get a clear picture of the complexity of a given proteome, researchers have to be confident they are seeing all the participating proteins and peptides. Unfortunately, different isolation methods are biased toward different proteomic subpopulations. With this in mind, researchers at the Swiss Federal Institute of Technology and Seattle's Institute for Systems Biology performed a systematic analysis of three phosphoproteomic isolation methods to determine how much the three methods overlap.
 
As they report in Nature Methods, the researchers used phosphoramidate chemistry, immobilized metal affinity chromatography, and titanium oxide separation to isolate phosphopeptides from a trypsinized Drosophila cell extract.
 
Following the isolations, the researchers used LC-MS to compare protein patterns, finding modest overlap—about one-third—between the three isolation methods. They then used LC-MS/MS to identify specific peptides and found that the ~33% overlap was consistent at the sequence level.
 
The researchers were unable to make a definitive statement regarding the three methods because a "gold standard" complete phosphoproteome does not exist. However, they noted their results implied "that none of the methods by itself is currently able to comprehensively analyze a phosphoproteome."

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D rendering of motor neurons lit up with blue, purple, orange, and green coloring showing synapses against a black background.

Improving ALS research with pluripotent stem cell-derived models 

Discover new advancements in modeling amyotrophic lateral sclerosis.

Automating 3D cell selection

Discover precise automated tools for organoid and spheroid handling. 
An illustration of the tumor microenvironment, showing cancer cells, T cells, and nanoparticles interacting within a complex biological system

A closer look at the tumor microenvironment 

New technologies are allowing researchers to delve deeper into the complex tumor landscape.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue